NO20062362L - Injiserbart implantat med langvarig frigjoring som har en bionedbrytende kjerne og en bionedbrytende hud - Google Patents

Injiserbart implantat med langvarig frigjoring som har en bionedbrytende kjerne og en bionedbrytende hud

Info

Publication number
NO20062362L
NO20062362L NO20062362A NO20062362A NO20062362L NO 20062362 L NO20062362 L NO 20062362L NO 20062362 A NO20062362 A NO 20062362A NO 20062362 A NO20062362 A NO 20062362A NO 20062362 L NO20062362 L NO 20062362L
Authority
NO
Norway
Prior art keywords
drug
core
skin
biodegradable
polymer
Prior art date
Application number
NO20062362A
Other languages
English (en)
Norwegian (no)
Inventor
Hong Guo
Paul Ashton
Robert W Shimizu
David A Watson
Kang-Jye Chou
Original Assignee
Psivida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/714,549 external-priority patent/US8871241B2/en
Application filed by Psivida Inc filed Critical Psivida Inc
Publication of NO20062362L publication Critical patent/NO20062362L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Prostheses (AREA)
NO20062362A 2003-11-13 2006-05-23 Injiserbart implantat med langvarig frigjoring som har en bionedbrytende kjerne og en bionedbrytende hud NO20062362L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/714,549 US8871241B2 (en) 2002-05-07 2003-11-13 Injectable sustained release delivery devices
US54336804P 2004-02-09 2004-02-09
PCT/US2004/035430 WO2005051234A2 (fr) 2003-11-13 2004-10-26 Dispositifs d'administration injectables a liberation continue

Publications (1)

Publication Number Publication Date
NO20062362L true NO20062362L (no) 2006-08-13

Family

ID=34636703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062362A NO20062362L (no) 2003-11-13 2006-05-23 Injiserbart implantat med langvarig frigjoring som har en bionedbrytende kjerne og en bionedbrytende hud

Country Status (20)

Country Link
EP (2) EP1696822B1 (fr)
JP (3) JP5661226B2 (fr)
AT (1) ATE460901T1 (fr)
AU (1) AU2004292957C1 (fr)
CA (1) CA2545650C (fr)
CY (1) CY1114947T1 (fr)
DE (1) DE602004026106D1 (fr)
DK (1) DK1696822T3 (fr)
ES (2) ES2447816T7 (fr)
FR (1) FR14C0042I1 (fr)
HK (1) HK1148931A1 (fr)
IL (1) IL175584A (fr)
MX (1) MXPA06005431A (fr)
NO (1) NO20062362L (fr)
NZ (3) NZ547619A (fr)
PL (2) PL1696822T3 (fr)
PT (2) PT2233112E (fr)
SI (1) SI1696822T1 (fr)
TW (2) TWI445559B (fr)
WO (1) WO2005051234A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
NZ547619A (en) 2003-11-13 2009-06-26 Psivida Inc Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
CA2572592C (fr) 2004-07-02 2015-09-08 Eliot Lazar Dispositif de mise en place d'un moyen de traitement et methodes destinees a la mise en place dans l'oeil de ce type de moyen de traitement a l'aide dudit dispositif de mise en place
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
JP5208916B2 (ja) 2006-03-31 2013-06-12 キュー エル ティー インク． 鼻涙系用の薬物送達方法、構造および組成物
PL2155169T3 (pl) 2007-06-08 2016-09-30 Formulacja newirapiny o przedłużonym uwalnianiu
CA2698580C (fr) 2007-09-07 2016-10-11 Qlt Plug Delivery, Inc. Detection d'un implant lacrymal
FR2927798B1 (fr) * 2008-02-25 2011-03-04 C L Investissements Procede de fabrication d'un dispositif contraceptif intra-uterin et installation pour la mise en oeuvre de ce procede
US20100278895A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
WO2011079232A1 (fr) * 2009-12-23 2011-06-30 Psivida Us, Inc. Dispositifs d'administration à libération prolongée
KR20130086131A (ko) * 2010-04-06 2013-07-31 알러간, 인코포레이티드 전방내 약물 송달을 위한 서-방출 저장소 임플란트
WO2011146483A1 (fr) 2010-05-17 2011-11-24 Aerie Pharmaceuticals, Inc. Dispositifs d'administration de médicament pour administration d'agents thérapeutiques oculaires
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
CN103402582A (zh) * 2011-02-11 2013-11-20 普西维达公司 使用抗水肿疗法治疗黄斑水肿的方法
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130053794A1 (en) 2011-08-29 2013-02-28 Suzanne Cadden Sustained release delivery of active agents to treat glaucoma and ocular hypertension
BR112014004753A2 (pt) 2011-08-30 2017-03-28 Univ Gent formulação de liberação de multicamadas
JP2015512422A (ja) * 2012-05-30 2015-04-27 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 治療剤制御放出用の注射可能な生分解性粒子
JP6720447B2 (ja) 2014-12-18 2020-07-08 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 酸感受性薬剤の送達のための薬剤送達系
RU2019134877A (ru) * 2017-06-13 2021-07-13 Айпойнт Фармасьютикалс, Инк. Биоразрушаемое устройство для доставки лекарственного средства
FR3085841B1 (fr) * 2018-09-14 2020-12-04 Oreal Procede de preparation de capsules et systeme associe
EP3698841A1 (fr) * 2019-02-19 2020-08-26 L'oreal Dispositif d'injection
EP4121017A4 (fr) * 2020-03-17 2024-07-03 Aron H Blaesi Forme posologique structurée à multi-excipient expansible pour libération prolongée de médicament

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6051576A (en) 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5518672A (en) 1994-05-31 1996-05-21 Randcastle Extrusion Systems, Inc. Extrusion surge controller and method
US5486328A (en) 1994-05-31 1996-01-23 Randcastle Extrusion Systems, Inc. Extrusion surge suppressor and method
US5569429A (en) 1995-05-05 1996-10-29 Randcastle Extrusion Systems, Inc. Dynamic seal and sealing method
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
SE0001893D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab Medical arrangement
EP1408876A4 (fr) * 2001-06-22 2004-09-22 Durect Corp Implants coaxiaux a liberation prolongee d'ordre 0
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
WO2003051328A1 (fr) * 2001-12-18 2003-06-26 Novo Nordisk A/S Micro implant a dose solide
NZ547619A (en) 2003-11-13 2009-06-26 Psivida Inc Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin

Also Published As

Publication number Publication date
EP1696822B1 (fr) 2010-03-17
PL1696822T3 (pl) 2010-08-31
CA2545650A1 (fr) 2005-06-09
JP5526114B2 (ja) 2014-06-18
PT1696822E (pt) 2010-04-28
SI1696822T1 (sl) 2010-07-30
WO2005051234A2 (fr) 2005-06-09
TW201422269A (zh) 2014-06-16
FR14C0042I1 (fr) 2014-06-27
EP2233112B1 (fr) 2013-11-20
JP5918195B2 (ja) 2016-05-18
EP1696822A2 (fr) 2006-09-06
AU2004292957A1 (en) 2005-06-09
NZ547619A (en) 2009-06-26
EP2233112A2 (fr) 2010-09-29
DE602004026106D1 (de) 2010-04-29
PT2233112E (pt) 2014-02-27
AU2004292957B2 (en) 2010-09-09
IL175584A0 (en) 2006-09-05
ES2447816T3 (es) 2014-03-13
CY1114947T1 (el) 2016-12-14
TW200526285A (en) 2005-08-16
ES2447816T7 (es) 2014-06-25
ES2340389T3 (es) 2010-06-02
DK1696822T3 (da) 2010-05-17
JP2007512248A (ja) 2007-05-17
EP2233112A3 (fr) 2011-03-02
EP2233112B3 (fr) 2014-05-14
PL2233112T6 (pl) 2014-11-28
JP5661226B2 (ja) 2015-01-28
NZ575950A (en) 2010-06-25
ATE460901T1 (de) 2010-04-15
HK1148931A1 (en) 2011-09-23
WO2005051234A3 (fr) 2005-11-10
MXPA06005431A (es) 2007-01-25
IL175584A (en) 2015-05-31
AU2004292957C1 (en) 2011-04-28
JP2012072180A (ja) 2012-04-12
TWI496597B (zh) 2015-08-21
TWI445559B (zh) 2014-07-21
JP2014040479A (ja) 2014-03-06
CA2545650C (fr) 2015-08-18
PL2233112T3 (pl) 2014-05-30
NZ581461A (en) 2011-04-29

Similar Documents

Publication Publication Date Title
NO20062362L (no) Injiserbart implantat med langvarig frigjoring som har en bionedbrytende kjerne og en bionedbrytende hud
Flynn et al. Fiber templating of poly (2-hydroxyethyl methacrylate) for neural tissue engineering
US20190030309A1 (en) Method for manufacturing microneedle by using biocompatible polymer
WO2008139786A1 (fr) Dispositif à micro-aiguilles et son procédé de fabrication
WO2011012137A3 (fr) Dispositif médical de polyoléfine
ATE421316T1 (de) Herstellung von langzeit- arzneimittelabgabevorrichtungen mit polymeren auf polyurethanbasis
ATE427760T1 (de) Erodierbare polymere zur injektion
Johnson et al. Drug eluting implants in pharmaceutical development and clinical practice
NO20025759L (no) Formulering basert på heparin, glykosaminoglykan eller heparinoid, anvendelse av formuleringen og formuleringsbasen
DE60017956D1 (de) Biodegradierbare polymerzusammensetzung
NZ600921A (en) Intraocular drug delivery systems
BRPI0519739A2 (pt) combinaÇço compreendendo um agente fornecendo um sinal, um material de implante e uma droga
NO20060295L (no) Doseringsformer med vedvarende frigivning av anestetika for smertehandtering
WO2007081396A3 (fr) Initiateurs et matières polymères réticulables
Masood Application of fused deposition modelling in controlled drug delivery devices
SE0401182D0 (sv) Novel use of a viscoelastic composition
Duran et al. 3D printing of silicone and polyurethane elastomers for medical device application: A review
Silvestre et al. Microneedle arrays of polyhydroxyalkanoate by laser-based micromolding technique
Pothupitiya et al. Synthetic biodegradable polyesters for implantable controlled-release devices
PL1638534T3 (pl) Zastosowanie etanolu jako zmiękczacza do wytwarzania podskórnych implantów zawierających termolabilne substancje czynne rozproszone w matrycy PLGA
IN2012DN04939A (fr)
KR101697556B1 (ko) 마이크로 구조체 제조장치, 제조방법 및 이로부터 제조된 마이크로 구조체
WO2006084211A3 (fr) Articles thermoplastiques contenant un medicament
CY1114534T1 (el) Συσκευες ενεσιμης χορηγησης με παρατεταμενη αποδεσμευση
EP2072216A3 (fr) Procédé de fabrication et appareil de produits optiques